+1 415-686-8822
[email protected]
Facebook
Twitter
Linkedin
HAYAT PHARMACEUTICALS CONSULTING
If we don’t put our patients and clients first, we don’t have right to exist
Home
Services
Regulatory Meetings/ Filing/ Submissions
Due Diligence for Venture Capital (VC), Banks & Investment Firms
Selection of CDMO/Technology Transfer
Quality Audits
Pre-Clinical/Clinical Research
Resources
Testimonials
Request Consultation
Contact us
Career
Drug Development Consulting
X
Search
Search
Resources
ICH Q1E: Evaluation for Stability Data
Assigning retest period or expiry date for drug substance or drug product based on available stability data.